Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection
Open Access
- 15 November 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (10) , 1520-1523
- https://doi.org/10.1086/425359
Abstract
Oral miltefosine was administered to 39 human immunodeficiency virus (HIV)–infected patients with leishmaniasis for whom standard leishmaniasis treatKeywords
This publication has 10 references indexed in Scilit:
- Treatment of leishmaniasis in HIV-positive patientsPathogens and Global Health, 2003
- Recent understanding in the treatment of visceral leishmaniasis.Journal of Postgraduate Medicine, 2003
- Oral Miltefosine for Indian Visceral LeishmaniasisNew England Journal of Medicine, 2002
- A policy for leishmaniasis with respect to the prevention and control of drug resistanceTropical Medicine & International Health, 2001
- Treatment of American Cutaneous Leishmaniasis with Miltefosine, an Oral AgentClinical Infectious Diseases, 2001
- Suppression of Posttreatment Recurrence of Experimental Visceral Leishmaniasis in T-Cell-Deficient Mice by Oral MiltefosineAntimicrobial Agents and Chemotherapy, 2000
- Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in IndiaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2000
- Visceral Leishmanicidal Activity of Hexadecylphosphocholine (Miltefosine) in Mice Deficient in T Cells and Activated Macrophage Microbicidal MechanismsThe Journal of Infectious Diseases, 2000
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in miceAntimicrobial Agents and Chemotherapy, 1992